Exhibit 4.1
PURCHASE AGREEMENT
THIS
PURCHASE AGREEMENT (“Agreement”) is made as of the 6th
day of July, 2005 by and among Tegal Corporation, a Delaware
corporation (the “Company”), and the Investors set
forth on the signature pages affixed hereto (each an
“Investor” and collectively the
“Investors”).
Recitals
A.
The Company and the Investors are executing and delivering this
Agreement in reliance upon the exemption from securities
registration afforded by the provisions of Regulation D
(“Regulation D”), as promulgated by the U.S. Securities
and Exchange Commission (the “SEC”) under the
Securities Act of 1933, as amended; and
B.
The Investors wish to purchase from the Company, and the Company
wishes to sell and issue to the Investors, upon the terms and
conditions stated in this Agreement, (i) an aggregate of 34,615,385
shares (the “Shares”) of the Company’s Common
Stock, par value $0.01 per share (together with any securities into
which such shares may be reclassified the “Common
Stock”), at purchase price of $0.65 per share, and (ii)
warrants to purchase an aggregate of 17,307,692 shares of Common
Stock (subject to adjustment) at an exercise price of $1.00 per
share (subject to adjustment) in the form attached hereto as
Exhibit A (the “Warrants”); and
C.
Subject to the terms and conditions set forth herein, (i) 6,300,000
shares of Common Stock (the “Initial Shares”) and
Warrants to purchase an aggregate of 3,150,000 shares of Common
Stock (subject to adjustment) (the “Initial Warrants”
and, collectively with the Initial Shares, the “Initial
Securities”) will be issued and sold to the Investors on the
First Closing Date (as defined below) for an aggregate purchase
price of $4,095,000 (the “Initial Purchase
Price”).
D.
Subject to the terms and conditions set forth herein, (i)
28,315,385 shares of Common Stock (the “Remaining
Shares”) and Warrants to purchase an aggregate of 14,157,692
shares of Common Stock (subject to adjustment) (the
“Remaining Warrants” and, collectively with the
Remaining Shares, the “Remaining Securities”) will be
issued and sold to the Investors on the Second Closing Date (as
defined below) for an aggregate purchase price of $18,405,000 (the
“Remaining Purchase Price”).
E.
Contemporaneous with the sale of the Initial Shares and the Initial
Warrants, the parties hereto will execute and deliver a
Registration Rights Agreement, in the form attached hereto as
Exhibit B (the “Registration Rights Agreement”),
pursuant to which the Company will agree to provide certain
registration rights under the Securities Act of 1933, as amended,
and the rules and regulations promulgated thereunder, and
applicable state securities laws.
In
consideration of the mutual promises made herein and for other good
and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto agree as
follows:
1.
Definitions . In addition to those terms defined above and
elsewhere in this Agreement, for the purposes of this Agreement,
the following terms shall have the meanings set forth
below:
“
Affiliate ” means, with respect to any Person, any
other Person which directly or indirectly through one or more
intermediaries Controls, is controlled by, or is under common
control with, such Person.
“
Business Day ” means a day, other than a Saturday or
Sunday, on which banks in New York City are open for the general
transaction of business.
“
Company’s Knowledge ” means the actual knowledge
of the executive officers (as defined in Rule 405 under the 1933
Act) of the Company, after due inquiry.
“
Confidential Information ” means trade secrets,
confidential information and know-how (including but not limited to
ideas, formulae, compositions, processes, procedures and
techniques, research and development information, computer program
code, performance specifications, support documentation, drawings,
specifications, designs, business and marketing plans, and customer
and supplier lists and related information).
“
Control ” (including the terms
“controlling”, “controlled by” or
“under common control with”) means the possession,
direct or indirect, of the power to direct or cause the direction
of the management and policies of a Person, whether through the
ownership of voting securities, by contract or
otherwise.
“
Effective Date ” means the date on which the initial
Registration Statement is declared effective by the SEC.
“
Effectiveness Deadline ” means the date on which the
initial Registration Statement is required to be declared effective
by the SEC under the terms of the Registration Rights
Agreement.
“
Initial Warrant Shares ” means the shares of Common
Stock issuable upon the exercise of the Initial
Warrants.
“
Intellectual Property ” means all of the following:
(i) patents, patent applications, patent disclosures and inventions
(whether or not patentable and whether or not reduced to practice);
(ii) trademarks, service marks, trade dress, trade names, corporate
names, logos, slogans and Internet domain names, together with all
goodwill associated with each of the foregoing; (iii) copyrights
and copyrightable works; (iv) registrations, applications and
renewals for any of the foregoing; and (iv) proprietary computer
software (including but not limited to data, data bases and
documentation).
“
Material Adverse Effect ” means a material adverse
effect on (i) the assets, liabilities, results of operations,
condition (financial or otherwise), business, or prospects of the
Company and its Subsidiaries taken as a whole (excluding any
reduction in the trading price of the Common Stock occurring as a
result of the announcement or consummation of the transactions
contemplated hereby), or (ii) the ability of the Company to perform
its obligations under the Transaction Documents.
“
Nasdaq ” means The Nasdaq Stock Market,
Inc.
“
Permitted Liens ” means (i) mechanics’,
carriers’, or workmen’s, repairmen’s or similar
liens arising or incurred in the ordinary course of business, (ii)
liens for taxes, assessments and other governmental charges that
are not due and payable or which may hereafter be paid without
penalty or which are being contested in good faith by appropriate
proceedings and (iii) other imperfections of title or encumbrances,
if any, that do not, individually or in the aggregate, materially
impair the use or value of the property to which they
relate.
“
Person ” means an individual, corporation,
partnership, limited liability company, trust, business trust,
association, joint stock company, joint venture, sole
proprietorship, unincorporated organization, governmental authority
or any other form of entity not specifically listed
herein.
“
Proposal ” has the meaning set forth in Section
7.9.
“
SEC Filings ” has the meaning set forth in Section
4.6.
“
Registration Statement ” has the meaning set forth in
the Registration Rights Agreement.
“
Remaining Warrant Shares ” means the shares of Common
Stock issuable upon the exercise of the Remaining
Warrants.
“
Securities ” means the Initial Securities and the
Remaining Securities.
“
Subsidiary ” of any Person means another Person, an
amount of the voting securities, other voting ownership or voting
partnership interests of which is sufficient to elect at least a
majority of its Board of Directors or other governing body (or, if
there are no such voting interests, 50% or more of the equity
interests of which) is owned directly or indirectly by such first
Person.
“
Transaction Documents ” means this Agreement, the
Warrants and the Registration Rights Agreement.
“
Warrant Shares ” means the shares of Common Stock
issuable upon the exercise of the Warrants.
“
1933 Act ” means the Securities Act of 1933, as
amended, or any successor statute, and the rules and regulations
promulgated thereunder.
“
1934 Act ” means the Securities Exchange Act of 1934,
as amended, or any successor statute, and the rules and regulations
promulgated thereunder.
2.
Purchase and Sale of the Shares and Warrants .
(a)
Subject to the terms and conditions of this Agreement, on the First
Closing Date, each of the Investors shall severally, and not
jointly, purchase, and the Company shall sell and issue to the
Investors, the Initial Shares and the Initial Warrants in the
respective amounts set forth opposite the Investors’ names on
the signature pages attached hereto in exchange for the Initial
Purchase Price as specified in Section 3(a) below.
(b)
Subject to the terms and conditions of this Agreement, on the
Second Closing Date, each of the Investors shall severally, and not
jointly, purchase, and the Company shall sell and issue to the
Investors, the Remaining Shares and the Remaining Warrants in the
respective amounts set forth opposite the Investors’ names on
the signature pages attached hereto in exchange for the Remaining
Purchase Price as specified in Section 3(b) below.
3.
Closing .
(a)
Upon confirmation that the other conditions to the First Closing
specified herein have been satisfied or duly waived by the
Investors, the Company shall deliver to Lowenstein Sandler PC, in
trust, a certificate or certificates, registered in such name or
names as the Investors may designate, representing the Initial
Shares and the Initial Warrants, with instructions that such
certificates are to be held for release to the Investors only upon
payment in full of the Initial Purchase Price to the Company by all
the Investors. Upon such receipt by Lowenstein Sandler PC of the
certificates, each Investor shall promptly, but no more than one
Business Day thereafter, cause a wire transfer in same day funds to
be sent to the account of the Company as instructed in writing by
the Company, in an amount representing such Investor’s pro
rata portion of the Initial Purchase Price as set forth on the
signature pages to this Agreement. On the date (the “First
Closing Date”) the Company receives the Initial Purchase
Price, the certificates evidencing the Initial Shares and the
Initial Warrants shall be released to the Investors (the
“First Closing”). The First Closing shall take place at
the offices of Lowenstein Sandler PC, 1251 Avenue of the Americas,
18th Floor, New York, New York 10020, or at such other location and
on such other date as the Company and the Investors shall mutually
agree.
(b)
Upon confirmation that the other conditions to the Second Closing
specified herein have been satisfied or duly waived by the
Investors, the Company shall deliver to Lowenstein Sandler PC, in
trust, a certificate or certificates, registered in such name or
names as the Investors may designate, representing the Remaining
Shares and the Remaining Warrants, with instructions that such
certificates are to be held for release to the Investors only upon
payment in full of the Remaining Purchase Price to the Company by
all the Investors. Upon such receipt by Lowenstein Sandler PC of
the certificates, each Investor shall promptly, but no more than
one Business Day thereafter, cause a wire transfer in same day
funds to be sent to the account of the Company as instructed in
writing by the Company, in an amount representing such
Investor’s pro rata portion of the Remaining Purchase Price
as set forth on the signature pages to this Agreement. On the date
(the “Second Closing Date”) the Company receives the
Second Purchase Price, the certificates evidencing the Remaining
Shares and the Remaining Warrants shall be released to the
Investors (the “Second Closing”). The Second Closing
shall take place at the offices of Lowenstein Sandler PC, 1251
Avenue of the Americas, 18th Floor, New York, New York 10020, or at
such other location and on such other date as the Company and the
Investors shall mutually agree.
4.
Representations and Warranties of the Company . The Company
hereby represents and warrants to the Investors that, except as set
forth in the schedules delivered herewith (collectively, the
“Disclosure Schedules”):
4.1
Organization, Good Standing and Qualification . Each of the
Company and its Subsidiaries is a corporation duly organized,
validly existing and in good standing under the laws of the
jurisdiction of its incorporation and has all requisite corporate
power and authority to carry on its business as now conducted and
to own its properties. Each of the Company and its Subsidiaries is
duly qualified to do business as a foreign corporation and is in
good standing in each jurisdiction in which the conduct of its
business or its ownership or leasing of property makes such
qualification or leasing necessary unless the failure to so qualify
has not had and would not reasonably be expected to have a Material
Adverse Effect. The Company’s Subsidiaries are listed on
Schedule 4.1 hereto.
4.2
Authorization . The Company has full corporate power and
authority and, except for approval of the Proposal by its
stockholders as contemplated in Section 7.9, has taken all
requisite action on the part of the Company, its officers,
directors and stockholders necessary for (i) the authorization,
execution and delivery of the Transaction Documents, (ii) the
authorization of the performance of all obligations of the Company
hereunder or thereunder, and (iii) the authorization, issuance (or
reservation for issuance) and delivery of the Securities. The
Transaction Documents constitute the legal, valid and binding
obligations of the Company, enforceable against the Company in
accordance with their terms, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of
general applicability, relating to or affecting creditors’
rights generally.
4.3
Capitalization . Schedule 4.3 sets forth
as of the date hereof (a) the authorized capital stock of the
Company; (b) the number of shares of capital stock issued and
outstanding; (c) the number of shares of capital stock issuable
pursuant to the Company’s stock plans; and (d) the number of
shares of capital stock issuable and reserved for issuance pursuant
to securities (other than the Securities) exercisable for, or
convertible into or exchangeable for any shares of capital stock of
the Company. All of the issued and outstanding shares of the
Company’s capital stock have been duly authorized and validly
issued and are fully paid, nonassessable and free of pre-emptive
rights and were issued in full compliance with applicable state and
federal securities law and any rights of third parties. Except as
described on Schedule 4.3 , all of the issued and
outstanding shares of capital stock of each Subsidiary have been
duly authorized and validly issued and are fully paid,
nonassessable and free of pre-emptive rights, were issued in full
compliance with applicable state and federal securities law and any
rights of third parties and are owned by the Company, beneficially
and of record, subject to no lien, encumbrance or other adverse
claim. Except as described on Schedule 4.3 , no Person is
entitled to pre-emptive or similar statutory or contractual rights
with respect to any securities of the Company. Except as described
on Schedule 4.3 , there are no outstanding warrants,
options, convertible securities or other rights, agreements or
arrangements of any character under which the Company or any of its
Subsidiaries is or may be obligated to issue any equity securities
of any kind and except as contemplated by this Agreement, neither
the Company nor any of its Subsidiaries is currently in
negotiations for the issuance of any equity securities of any kind.
Except as described on Schedule 4.3 and except for the
Registration Rights Agreement, there are no voting agreements,
buy-sell agreements, option or right of first purchase agreements
or other agreements of any kind among the Company and any of the
securityholders of the Company relating to the securities of the
Company held by them. Except as described on Schedule 4.3
and except as provided in the Registration Rights Agreement, no
Person has the right to require the Company to register any
securities of the Company under the 1933 Act, whether on a demand
basis or in connection with the registration of securities of the
Company for its own account or for the account of any other
Person.
Except
as described on Schedule 4.3 , the issuance and sale of the
Securities hereunder will not obligate the Company to issue shares
of Common Stock or other securities to any other Person (other than
the Investors) and will not result in the adjustment of the
exercise, conversion, exchange or reset price of any outstanding
security.
Except
as described on Schedule 4.3 , the Company does not have
outstanding stockholder purchase rights or “poison
pill” or any similar arrangement in effect giving any Person
the right to purchase any equity interest in the Company upon the
occurrence of certain events.
4.4
Valid Issuance . The Shares have been duly and validly
authorized and, when issued and paid for pursuant to this
Agreement, will be validly issued, fully paid and nonassessable,
and shall be free and clear of all encumbrances and restrictions
(other than those created by the Investors), except for
restrictions on transfer set forth in the Transaction Documents or
imposed by applicable securities laws. The Warrants have been duly
and validly authorized. Upon the due exercise of the Warrants, the
Warrant Shares will be validly issued, fully paid and
non-assessable free and clear of all encumbrances and restrictions,
except for restrictions on transfer set forth in the Transaction
Documents or imposed by applicable securities laws and except for
those created by the Investors. The Company has reserved a
sufficient number of shares of Common Stock for issuance upon the
exercise of the Warrants, free and clear of all encumbrances and
restrictions, except for restrictions on transfer set forth in the
Transaction Documents or imposed by applicable securities laws and
except for those created by the Investors.
4.5
Consents . Except for approval of the Proposal by its
stockholders as contemplated in Section 7.9, the execution,
delivery and performance by the Company of the Transaction
Documents and the offer, issuance and sale of the Securities
require no consent of, action by or in respect of, or filing with,
any Person, governmental body, agency, or official other than
filings that have been made pursuant to applicable state securities
laws and post-sale filings pursuant to applicable state and federal
securities laws which the Company undertakes to file within the
applicable time periods. Subject to the accuracy of the
representations and warranties of each Investor set forth in
Section 5 hereof, the Company has taken all action necessary to
exempt (i) the issuance and sale of the Securities, (ii) the
issuance of the Warrant Shares upon due exercise of the Warrants,
and (iii) the other transactions contemplated by the Transaction
Documents from the provisions of any stockholder rights plan or
other “poison pill” arrangement, any anti-takeover,
business combination or control share law or statute binding on the
Company or to which the Company or any of its assets and properties
may be subject and any provision of the Company’s Certificate
of Incorporation or Bylaws that is or could reasonably be expected
to become applicable to the Investors as a result of the
transactions contemplated hereby, including without limitation, the
issuance of the Securities and the ownership, disposition or voting
of the Securities by the Investors or the exercise of any right
granted to the Investors pursuant to this Agreement or the other
Transaction Documents.
4.6
Delivery of SEC Filings . The Company has made available to
the Investors through the EDGAR system, true and complete copies of
the Company’s most recent Annual Report on Form 10-K for the
fiscal year ended March 31, 2004 (the “10-K”), and all
other reports filed by the Company pursuant to the 1934 Act since
the filing of the 10-K and prior to the date hereof (collectively,
the “SEC Filings”). The SEC Filings are the only
filings required of the Company pursuant to the 1934 Act for such
period.
4.7
Use of Proceeds . The net proceeds of the sale of the Shares
and the Warrants hereunder shall be used by the Company for working
capital and general corporate purposes.
4.8
No Material Adverse Change . Since March 31, 2004, except as
identified and described in the SEC Filings or as described on
Schedule 4.8, there has not been:
(i)
any change in the consolidated assets, liabilities, financial
condition or operating results of the Company from that reflected
in the financial statements included in the Company’s
Quarterly Report on Form 10-Q for the quarter ended December 31,
2004, except for changes in the ordinary course of business which
have not had and would not reasonably be expected to have a
Material Adverse Effect, individually or in the
aggregate;
(ii)
any declaration or payment of any dividend, or any authorization or
payment of any distribution, on any of the capital stock of the
Company, or any redemption or repurchase of any securities of the
Company;
(iii)
any material damage, destruction or loss, whether or not covered by
insurance to any assets or properties of the Company or its
Subsidiaries;
(iv)
any waiver, not in the ordinary course of business, by the Company
or any Subsidiary of a material right or of a material debt owed to
it;
(v)
any satisfaction or discharge of any lien, claim or encumbrance or
payment of any obligation by the Company or a Subsidiary, except in
the ordinary course of business and which is not material to the
assets, properties, financial condition, operating results or
business of the Company and its Subsidiaries taken as a whole (as
such business is presently conducted and as it is proposed to be
conducted);
(vi)
any change or amendment to the Company’s Certificate of
Incorporation or Bylaws, or material change to any material
contract or arrangement by which the Company or any Subsidiary is
bound or to which any of their respective assets or properties is
subject;
(vii)
any material labor difficulties or labor union organizing
activities with respect to employees of the Company or any
Subsidiary;
(viii)
any material transaction entered into by the Company or a
Subsidiary other than in the ordinary course of
business;
(ix)
the loss of the services of any key employee, or material change in
the composition or duties of the senior management of the Company
or any Subsidiary;
(x)
the loss or threatened loss of any customer which has had or would
reasonably be expected to have a Material Adverse Effect;
or
(xi)
any other event or condition of any character that has had or would
reasonably be expected to have a Material Adverse
Effect.
4.9
SEC Filings; S-3 Eligibility .
(a)
At the time of filing thereof, the SEC Filings complied as to form
in all material respects with the requirements of the 1934 Act and
did not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements
made therein, in the light of the circumstances under which they
were made, not misleading.
(b)
Each registration statement and any amendment thereto filed by the
Company since January 1, 2002 pursuant to the 1933 Act and the
rules and regulations thereunder, as of the date such statement or
amendment became effective, complied as to form in all material
respects with the 1933 Act and did not contain any untrue statement
of a material fact or omit to state any material fact required to
be stated therein or necessary in order to make the statements made
therein not misleading; and each prospectus filed pursuant to Rule
424(b) under the 1933 Act, as of its issue date and as of the
closing of any sale of securities pursuant thereto did not contain
any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order
to make the statements made therein, in the light of the
circumstances under which they were made, not
misleading.
(c)
The Company is eligible to use Form S-3 to register the resale of
the Registrable Securities (as such term is defined in the
Registration Rights Agreement) by the Investors as contemplated by
the Registration Rights Agreement.
4.10
No Conflict, Breach, Violation or Default . Subject to the
approval of the Proposal by its stockholders as contemplated in
Section 7.9, the execution, delivery and performance of the
Transaction Documents by the Company and the issuance and sale of
the Securities will not conflict with or result in a breach or
violation of any of the terms and provisions of, or constitute a
default under (i) the Company’s Certificate of Incorporation
or the Company’s Bylaws, both as in effect on the date hereof
(true and complete copies of which have been made available to the
Investors through the EDGAR system), or (ii)(a) any statute, rule,
regulation or order of any governmental agency or body or any
court, domestic or foreign, having jurisdiction over the Company,
any Subsidiary or any of their respective assets or properties, or
(b) any agreement or instrument to which the Company or any
Subsidiary is a party or by which the Company or a Subsidiary is
bound or to which any of their respective assets or properties is
subject, other than a conflict, breach or default that would not
reasonably be expected to have a Material Adverse
Effect.
4.11
Tax Matters . The Company and each Subsidiary has timely
prepared and filed all tax returns required to have been filed by
the Company or such Subsidiary with all appropriate governmental
agencies and timely paid all taxes shown thereon or otherwise owed
by it, except as would not reasonably be expected to have a
Material Adverse Effect. The charges, accruals and reserves on the
books of the Company in respect of taxes for all fiscal periods are
adequate in all material respects, and there are no material unpaid
assessments against the Company or any Subsidiary. All taxes and
other assessments and levies that the Company or any Subsidiary is
required to withhold or to collect for payment have been duly
withheld and collected and paid to the proper governmental entity
or third party when due. There are no tax liens or claims pending
or, to the Company’s Knowledge, threatened against the
Company or any Subsidiary or any of their respective assets or
property, other than Permitted Liens. Except as described on
Schedule 4.11 , there are no outstanding tax sharing
agreements or other such arrangements between the Company and any
Subsidiary or other corporation or entity.
4.12
Title to Properties . Except as disclosed in the SEC
Filings, the Company and each Subsidiary has good and marketable
title to all properties and assets owned by it, in each case free
from liens, encumbrances and defects, other than Permitted Liens;
and except as disclosed in the SEC Filings, the Company and each
Subsidiary holds any leased real or personal property under valid
and enforceable leases with no exceptions that would materially
interfere with the use made or currently planned to be made thereof
by them.
4.13
Certificates, Authorities and Permits . The Company and each
Subsidiary possess adequate certificates, authorities or permits
issued by appropriate governmental agencies or bodies necessary to
conduct the business now operated by it, except as would not
reasonably be expected to have a Material Adverse Effect, and
neither the Company nor any Subsidiary has received any written
notice of proceedings relating to the revocation or modification of
any such certificate, authority or permit that, if determined
adversely to the Company or such Subsidiary, would reasonably be
expected to have a Material Adverse Effect, individually or in the
aggregate.
4.14
Labor Matters .
(a)
Except as set forth on Schedule 4.14 , the Company is not a
party to or bound by any collective bargaining agreements or other
agreements with labor organizations. The Company has not violated
in any material respect any laws, regulations, orders or contract
terms, affecting the collective bargaining rights of employees,
labor organizations or any laws, regulations or orders affecting
employment discrimination, equal opportunity employment, or
employees’ health, safety, welfare, wages and
hours.
(b)
(i) There are no labor disputes existing, or to the Company’s
Knowledge, threatened, involving strikes, slow-downs, work
stoppages, job actions, disputes, lockouts or any other disruptions
of or by the Company’s employees, (ii) there are no unfair
labor practices or petitions for election pending or, to the
Company’s Knowledge, threatened before the National Labor
Relations Board or any other federal, state or local labor
commission relating to the Company’s employees, (iii) no
demand for recognition or certification heretofore made by any
labor organization or group of employees is pending with respect to
the Company and (iv) to the Company’s Knowledge, the Company
enjoys good labor and employee relations with its employees and
labor organizations.
(c)
The Company is in compliance in all material respects with all
applicable laws respecting employment (including laws relating to
classification of employees and independent contractors) and
employment practices, terms and conditions of employment, wages and
hours, and immigration and naturalization. There no claims are
pending against the Company before the Equal Employment Opportunity
Commission or any other administrative body or in any court
asserting any violation of Title VII of the Civil Rights Act of
1964, the Age Discrimination Act of 1967, 42 U.S.C. §§
1981 or 1983 or any other federal, state or local Law, statute or
ordinance barring discrimination in employment.
(d)
Except as disclosed in the SEC Filings or as described on
Schedule 4.14 , the Company is not a party to, or bound by,
any employment or other contract or agreement that contains any
severance, termination pay or change of control liability or
obligation, including, without limitation, any “excess
parachute payment,” as defined in Section 2806(b) of the
Internal Revenue Code.
(e)
Except as specified in Schedule 4.14 , each of the
Company’s employees is a Person who is either a United States
citizen or a permanent resident entitled to work in the United
States. To the Company’s Knowledge, the Company has no
liability for the improper classification by the Company of such
employees as independent contractors or leased employees prior to
the Closing.
4.15
Intellectual Property .
(a)
To the Company’s Knowledge, all Intellectual Property of the
Company and its Subsidiaries is valid and enforceable. No
Intellectual Property owned by the Company or its Subsidiaries
which is necessary for the conduct of Company’s and each of
its Subsidiaries’ respective businesses as currently
conducted has been or is now involved in any cancellation, dispute
or litigation, and, to the Company’s Knowledge, no such
action is threatened. No issued patent owned by the Company or its
Subsidiaries has been or is now involved in any interference,
reissue, re-examination or opposition proceeding.
(b)
All of the in-bound licenses and sublicenses and consent, royalty
or other agreements concerning Intellectual Property which are
necessary for the conduct of the Company’s and each of its
Subsidiaries’ respective businesses as currently conducted to
which the Company or any Subsidiary is a party (other than
generally commercially available, non-custom, off-the-shelf
software application programs having a retail acquisition price of
less than $10,000 per license) (collectively, “In-Bound
License Agreements”) are, to the Company’s Knowledge,
valid and binding obligations of the Company or its Subsidiaries,
as the case may be, enforceable in accordance with their terms,
except to the extent that enforcement thereof may be limited by
bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance or other similar laws affecting the enforcement of
creditors’ rights generally, and, to the Company’s
Knowledge, neither the Company nor any of its Subsidiaries are, as
of the date of this Agreement, in material breach of any of their
respective obligations under any such In-Bound License
Agreements.
(c)
The Company and its Subsidiaries own or have the valid right to use
all of the Intellectual Property that is necessary for the conduct
of the Company’s and each of its Subsidiaries’
respective businesses as currently conducted and for the ownership,
maintenance and operation of the Company’s and its
Subsidiaries’ properties and assets, free and clear of all
liens, encumbrances, adverse claims or, with respect to
Intellectual Property owned by the Company or its Subsidiaries,
obligations to license such Intellectual Property, other than
licenses of the Intellectual Property owned by the Company or any
Subsidiary that are entered into in the ordinary course of the
Company’s or its Subsidiaries’ businesses. To the
Company’s Knowledge, the Company and its Subsidiaries have a
valid and enforceable right to use all third party Intellectual
Property and Confidential Information used or held for use in the
respective businesses of the Company and its
Subsidiaries.
(d)
To the Company’s Knowledge, the conduct of the
Company’s and its Subsidiaries’ businesses as currently
conducted does not infringe or otherwise materially impair or
conflict with (collectively, “Infringe”) any
Intellectual Property rights of any third party and, to the
Company’s Knowledge, the Intellectual Property owned by the
Company and its Subsidiaries which is necessary for the conduct of
Company’s and each of its Subsidiaries’ respective
businesses as currently conducted are not being Infringed by any
third party. There is no litigation or court order pending or
outstanding or, to the Company’s Knowledge, threatened or
imminent, that seeks to limit or challenge or that concerns the
ownership, use, validity or enforceability of any Intellectual
Property owned by the Company or its Subsidiaries or the
Company’s and its Subsidiaries’ use of any Intellectual
Property owned by a third party, and, to the Company’s
Knowledge, there is no valid basis for the same.
(e)
To the Company’s Knowledge, the consummation of the
transactions contemplated hereby and by the other Transaction
Documents will not result in the (i) loss, material impairment of
or material restriction on any of the Intellectual Property or
Confidential Information owned by the Company or its Subsidiaries
which is necessary for the conduct of Company’s and each of
its Subsidiaries’ respective businesses as currently
conducted or (ii) material breach of any In-Bound License
Agreement.
(f)
The Company and its Subsidiaries have taken reasonable steps to
protect the Company’s and its Subsidiaries’ rights in
their Intellectual Property and Confidential Information. Each
employee, consultant and contractor who has had access to the
Company’s or its Subsidiaries’ Confidential Information
which is necessary for the conduct of Company’s and each of
its Subsidiaries’ respective businesses as currently
conducted has executed an agreement to maintain the confidentiality
of such Confidential Information. To the Company